Bruno De Geest is a visiting scientists to the VIB-UGent Center for Inflammation Research where he shares his expertise on the interface between materials chemistry and immunology. He has a strong interest in engineering the immune system via functional materials that can either modulate the pharmacokinetic and pharmacodynamic profile of immuno-modulatory stimuli and antigens. Bruno De Geest and his team combine this with developing strategies that modulate the interaction between immune cells and cancer cells. Their endeavours focus on engineering innate immune activation, cancer vaccines and T cell engineering.
Bruno De Geest is a Principal investigator at the Biopharmaceutical Technology Unit, Department of Pharmaceutics and a Full professor of this department at the Ghent University.
Bruno De Geest is also a Group Leader at CRIG,